PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

Erstveröffentlichung
2021Authors
Stein, Alexander
Simnica, Donjete
Schultheiß, Christoph
Scholz, Rebekka
Tintelnot, Joseph
Wissenschaftlicher Artikel
Published in
Journal for ImmunoTherapy of Cancer ; 9 (2021), 7. - Art.-Nr. e002844. - eISSN 2051-1426
Link to publication
https://dx.doi.org/10.1136/jitc-2021-002844Institutions
UKU. Klinik für Innere Medizin ISubject headings
[Free subject headings]: immunotherapy | biomarkers | tumor | clinical trials | phase II as topic | gastrointestinal neoplasms | translational medical research | ACQUIRED-RESISTANCE | KRAS MUTATIONS | EGFR BLOCKADE | CETUXIMAB | EVOLUTION | DNA | IDENTIFICATION | CYTOTOXICITY | EMERGENCE | NIVOLUMAB[DDC subject group]: DDC 610 / Medicine & health